Mechanistic Evaluation on Sorafenib Induced Hypophosphatemia.
Status:
Terminated
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to:
1. To elucidate the mechanism involved in the sorafenib-induced hypophosphatemia and
possible early effect of hypophosphatemia on bone mineral density
2. A secondary objective to assess the effect sorafenib treatment on evaluate left
ventricular function (LVEF) and Beta-type natriuretic peptide in plasma.